[
    [
        {
            "time": "",
            "original_text": "药明康德(02359)澄清涉及股东入股等媒体报道内容与事实情况不符",
            "features": {
                "keywords": [
                    "药明康德",
                    "澄清",
                    "股东入股",
                    "媒体报道",
                    "事实不符"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "药明康德(02359)澄清涉及股东入股等媒体报道内容与事实情况不符",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "药明康德(603259.SH)称：公司股本形成过程中不存在相关报道所述IPO之前大股东以不合理低价突击入股的情况",
            "features": {
                "keywords": [
                    "药明康德",
                    "股本形成",
                    "IPO",
                    "大股东",
                    "低价突击入股",
                    "不存在"
                ],
                "sentiment_score": 0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "药明康德(603259.SH)称：公司股本形成过程中不存在相关报道所述IPO之前大股东以不合理低价突击入股的情况",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "药明康德：不存在IPO之前大股东以不合理低价突击入股的情况",
            "features": {
                "keywords": [
                    "药明康德",
                    "IPO",
                    "大股东",
                    "低价突击入股",
                    "不存在"
                ],
                "sentiment_score": 0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "药明康德：不存在IPO之前大股东以不合理低价突击入股的情况",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "药明康德澄清：不存在相关报道所述IPO之前大股东以不合理低价突击入股的情况",
            "features": {
                "keywords": [
                    "药明康德",
                    "澄清",
                    "IPO",
                    "大股东",
                    "低价突击入股",
                    "不存在"
                ],
                "sentiment_score": 0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "药明康德澄清：不存在相关报道所述IPO之前大股东以不合理低价突击入股的情况",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "科技赋能传统医疗，药明康德参与惠每科技C轮3000万美元融资",
            "features": {
                "keywords": [
                    "药明康德",
                    "科技赋能",
                    "传统医疗",
                    "惠每科技",
                    "融资"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "科技赋能传统医疗，药明康德参与惠每科技C轮3000万美元融资",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "外资最爱哪些股票？QFII最新重仓股来了！（附增减持排行榜）",
            "features": {
                "keywords": [
                    "外资",
                    "QFII",
                    "重仓股",
                    "增减持排行榜"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "外资最爱哪些股票？QFII最新重仓股来了！（附增减持排行榜）",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业跨市场周报:从“中国新”走向“全球新”",
            "features": {
                "keywords": [
                    "医药生物",
                    "跨市场",
                    "周报",
                    "中国新",
                    "全球新"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业跨市场周报:从“中国新”走向“全球新”",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        }
    ]
]